Abstract:Background: Periodontal disease results in oral dysbiosis, increasing plaque virulence and oxidative stress. Stannous fluoride (SnF2) binds lipopolysaccharides to reduce plaque virulence. This study prospectively assessed SnF2 effects on oxidative stress in adults with gingivitis. Methods: This was a 2-month, single-center, single-treatment clinical trial. Twenty "disease" (> 20 bleeding sites with ≥ 3 pockets 3 mm-4 mm deep) and 20 "healthy" (≤ 3 bleeding sites with pockets ≤ 2 mm deep) adults were enrolled. All participants were instructed to use SnF2 dentifrice twice daily for 2 months. An oral examination, Modified Gingival Index (MGI) examination and Gingival Bleeding Index (GBI) examination were conducted at baseline, 1 month and 2 months. Gingival crevicular fluid (GCF), saliva, oral lavage and supragingival plaque were collected at each visit to evaluate: Endotoxins, Protein Carbonyls, L-lactate dehydrogenase (LDH), Ferric reducing antioxidant power (FRAP), Oxidized low density lipoproteins (oxi-LDL), IL-6 and C-reactive protein (CRP). A subset-analysis examined participants considered at higher risk of cardiovascular disease. Change-from-baseline analyses within each group were of primary interest. Results: The disease group showed statistically significant reductions in GBI at Month 1 (67%) and Month 2 (85%) and in MGI at Month 1 (36%) and Month 2 (51%) versus baseline (p < 0.001). At baseline, the disease group showed greater LDH in GCF and oxi-LDL levels in saliva versus the healthy group (p ≤ 0.01). Total antioxidant capacity (FRAP) in saliva increased versus baseline for the disease group at Months 1 and 2 (p < 0.05), and levels for the disease group were greater than the healthy group at both timepoints (p < 0.05). SnF2 treatment reduced endotoxins (lavage) for both disease and healthy groups at Month 2 (p ≤ 0.021) versus baseline. There was a reduction in oxidative stress markers, namely protein carbonyl in saliva, at Months 1 and 2 (p < 0.001) for both groups and a reduction in cytokine IL-6 (lavage) in the disease group at Month 2 (p = 0.005). A subset analysis of participants at higher coronary disease risk showed reductions in endotoxins in lavage, oxi-LDL, and CRP in saliva at Month 2 (p ≤ 0.04). Conclusion: SnF2 dentifrice use reversed gingival inflammation, suppressed endotoxins and reduced some harmful oxidant products in saliva and gingiva. Clinical trial registration: Clinicaltrials.gov NCT05326373, registered on 13/04/2022.

A Randomized Clinical Trial to Measure the Erosion Protection Benefits of a Novel Stabilized Stannous Fluoride Dentifrice Versus a Control Dentifrice.

Efficacy of a Stannous-containing Dentifrice for Protecting Against Combined Erosive and Abrasive Tooth Wear in Situ.

A Randomized Cross-over Clinical Trial to Evaluate the Effect of a 0.454% Stannous Fluoride Dentifrice on the Reduction of Oral Malodor.

A Randomized Clinical Trial to Assess Anti-Plaque Effects of an Oral Hygiene Regimen with A Stannous-Containing Sodium Fluoride Dentifrice, Advanced Manual Toothbrush, and Cpc Rinse

Efficacy of nano-carbonate apatite dentifrice in relief from dentine hypersensitivity following non-surgical periodontal therapy: a randomized controlled trial

Remineralisation of Enamel and Dentine with Stabilised Stannous Fluoride Dentifrices in a Randomised Cross-over in situ Trial

Randomized Controlled Trials Assessing Exposure Frequency Effects of Stannous Fluoride on Gingivitis

In situ efficacy of an experimental toothpaste on enamel rehardening and prevention of demineralisation: a randomised, controlled trial

Influence of Different Mouthwashes on the Efficacy of Fluoridated Dentifrices in Prevention of Enamel Erosion: An In Vitro Study

Better living through chemistry? A randomized, double-blind controlled study evaluating the efficacy of plaque control and gingival health impacts of a novel stannous fluoride-containing gel

Preventive effects of dentifrice containing 5000 ppm fluoride against dental erosion in situ

Effects of stannous fluoride dentifrice on gingival health and oxidative stress markers: a prospective clinical trial

Randomized clinical trial of the efficacy of dentifrices containing 1.5% arginine, an insoluble calcium compound and 1450 ppm fluoride over two years.

In situ remineralisation of eroded enamel lesions by NaF rinses

Effects of a stabilized stannous fluoride dentifrice on clinical, immunomodulatory, and microbial outcomes in a human experimental gingivitis model

Extrinsic stain prevention with a combination dentifrice containing calcium phosphate surface active builders compared to two marketed controls

Enamel erosion and prevention efficacy characterized by confocal laser scanning microscope

Pilot clinical study to evaluate the efficacy of a professionally delivered high fluoride varnish on erosive tooth wear in an in-situ model

Reduction in erosive tooth wear using stannous fluoride-containing dentifrices: a meta-analysis

Breath Malodor Reduction with Use of a Stannous-Containing Sodium Fluoride Dentifrice: a Meta-Analysis of Four Randomized and Controlled Clinical Trials.

Conventional and anti-erosion fluoride toothpastes: effect on enamel erosion and erosion-abrasion